Clinical Trial: Calorie Restricted Dietary Intervention in Type 2 Diabetes Patients With Obesity for Remission

U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07753447) titled 'Calorie Restricted Dietary Intervention in Type 2 Diabetes Patients With Obesity for Remission' on July 31, 2025.

Brief Summary: This study aims to induce remission of type 2 diabetes through dietary intervention for weight reduction.

Study Start Date: July 01, 2025

Study Type: INTERVENTIONAL

Condition: Diabetes, Type 2 Obesity &Amp; Overweight

Intervention: DRUG: Contrave ER

Contrave is an extended-release combination of naltrexone and bupropion, approved for chronic weight management. It acts on the central nervous system to reduce appetite and control food cravings.

COMBINATION_PRODUCT: Low-calorie meal box

The meal boxes...